➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Baxter
Dow
AstraZeneca
Boehringer Ingelheim

Last Updated: August 10, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: LISDEXAMFETAMINE DIMESYLATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

LISDEXAMFETAMINE DIMESYLATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Shire LLC 59417-101-10 100 CAPSULE in 1 BOTTLE (59417-101-10)
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Shire LLC 59417-102-10 100 CAPSULE in 1 BOTTLE (59417-102-10)
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Shire LLC 59417-103-10 100 CAPSULE in 1 BOTTLE (59417-103-10)
Shire Development VYVANSE lisdexamfetamine dimesylate CAPSULE;ORAL 021977 NDA Shire LLC 59417-104-10 100 CAPSULE in 1 BOTTLE (59417-104-10)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
AstraZeneca
Dow
Medtronic
McKinsey